Serum vascular endothelial growth factor is a potential biomarker of metastatic recurrence after curative resection of hepatocellular carcinoma

查看全文 作　　者：Qi [1]Niu;Zhao You [1]Tang;Zeng Chen [1]Ma;Lun Xiu [1]Qin;Lian Hai [1]Zhang

机构地区：[1]Liver Cancer Institute&Zhongshan Hospital,Shanghai Medical University,Shanghai 200032,China

出　　处：《World Journal of Gastroenterology》索引2000年第6卷第4期,共4页

基　　金：the Shanghai Leading Medical Subjects Grant(№983001);State Key Basic Research Grant(№G1998051211)for financial supports. 摘　　要：INTRODUCTIONHepatocellular carcinoma(HCC)is one of the mostcommon malignancies in China.To date,surgery is stillthe best solution to it.However,metastatic recurrencesafter curative hepatic resections are very common.Tang etal have reported that recurrence rate within 5 years 关键词：ENDOTHELIUM vascular ENDOTHELIAL growth factor carcinoma hepatocellular enzyme-linked IMMUNOSORBENT assay LIVER neoplasms LIVER cirrhosis IMMUNOHISTOCHEMISTRY

相关文献

参考文献（35）
引证文献（21）
耦合文献（83）

参考文献(35)

引证文献(21)

耦合文献(83)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

Serum vascular endothelial growth factor is a potential biomarker of metastatic recurrence after curative resection of hepatocellular carcinoma

参考文献(35)

引证文献(21)

耦合文献(83)

用户提示